What’s in Store for HIV Prevention in the Future?

Once upon a time, our HIV prevention toolkit consisted of just one lousy, dull instrument: condoms.

Nowadays, we have not only condoms in all colors, shapes and sizes, but also female condoms (hint: you don’t have to be female to use them), pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP) and the mama of all discoveries: HIV treatment as prevention (TasP). And exciting research keeps chugging along, seeking provide even more, safer, sexier, accessible ways for people living with and without HIV to get down without concern about HIV transmission.

Here are a few of the tools currently in the study “pipeline” that will shape the future of HIV prevention.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below